Xconomy
Events, News, Syndication, Xconomy »
Announcing Xconomy Napa Summit 2013: New Rules for Growth |  |
|
Posted by sandiegobiotech April 29th, 2013 .
| |
| No Comments |
Finally, the economy seems to be heading in the right direction, but frustratingly slowly—and peril lurks around every sequester corner. Is that the new normal in this age of rising healthcare costs,…
[[Click headline to continue reading.]]
News, Syndication, Xconomy »
Six Reasons Why Illumina Has Nothing to Fear from Thermo/Life | |
|
Posted by sandiegobiotech April 29th, 2013 .
| |
| No Comments |
Illumina doesn’t need luck. But the San Diego-based company just caught a break this month, which will make it easier to continue crushing all who dare challenge its supremacy in genomics. The gift…
[[Click headline to continue reading.]]
Drug Discovery, News, Syndication, Xconomy »
Using Bioprinting Technology, San Diego’s Organovo Makes 3D Tissue | |
|
Posted by sandiegobiotech April 23rd, 2013 .
| |
| No Comments |
Organovo, a San Diego regenerative medicine company developing bio-printing technology, says it has used its proprietary NovaGen bioprinter to produce 3D samples of human liver cells that show some…
[[Click headline to continue reading.]]
More...News, Syndication, Xconomy »
A Biotech Innovation Supply Chain: Reality or Fantasy? | |
|
Posted by sandiegobiotech April 22nd, 2013 .
| |
| No Comments |
Biotech has always been a bit like an open-air market bazaar. Now the industry needs to become a little more stable, more predictable. It ought to be part of something you could call an “innovation…
[[Click headline to continue reading.]]
News, Syndication, Xconomy »
San Diego Venture Funding Remains Flat in Q1 MoneyTree Data | |
|
Posted by sandiegobiotech April 18th, 2013 .
| |
| No Comments |
Venture capital activity in the San Diego region has remained flat for two consecutive quarters, with funding levels and deals for the first three months of 2013 coming in almost exactly the same as…
[[Click headline to continue reading.]]
More...News, Syndication, Xconomy »
San Diego Life Sciences Roundup: Life’s M&A Deal, Santarus, & More | |
|
Posted by sandiegobiotech April 18th, 2013 .
| |
| No Comments |
By far, the biggest life sciences news in the San Diego region over the past week was Thermo Fisher Scientific’s $13.6 billion acquisition of Life Technologies. I’ve compiled a special edition…
[[Click headline to continue reading.]]
News, Syndication, Xconomy »
Re-thinking Clinical Trials for the World of Crowdsourcing | |
|
Posted by sandiegobiotech April 16th, 2013 .
| |
| No Comments |
Disruption isn’t a word normally associated with clinical drug development, but nevertheless it is coming. We can feel the rumblings of it. New technologies and technology-enabled techniques for…
[[Click headline to continue reading.]]
Diagnostics, News, Syndication, Xconomy »
Thermo Fisher Scientific Acquires Life Technologies in $13.6B Deal | |
|
Posted by sandiegobiotech April 15th, 2013 .
| |
| No Comments |
Waltham, MA-based Thermo Fisher Scientific (NYSE: TMO) said today it will pay $13.6 billion to acquire Carlsbad, CA-based Life Technologies (NASDAQ: LIFE) following an auction that began in January…
[[Click headline to continue reading.]]
More...News, Syndication, Xconomy »
Big Data Is BS in Healthcare. When Will It Become Real? | |
|
Posted by sandiegobiotech April 15th, 2013 .
| |
| No Comments |
Tech entrepreneurs have been raving for a while now about big data changing the world, and it’s mostly bullshit. Venture capitalist Brad Feld made this point, more or less, when he was being…
[[Click headline to continue reading.]]
Drug Development, News, Syndication, Xconomy »
Rare FDA Ruling Triggers Stampede for Acadia Pharmaceuticals | |
|
Posted by sandiegobiotech April 11th, 2013 .
| |
| No Comments |
How often does the FDA tell a drug developer to dispense with a requisite, second late-stage trial—and to proceed with filing a new drug application? Shares of San Diego’s Acadia…
[[Click headline to continue reading.]]
